CG
EBS icon

Cutler Group’s Emergent Biosolutions EBS Stock Holding History

Cutler Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-203
Closed -$4K – 4576
2022
Q3 		$4K Sell
203
-1,032
-84% -$28.7K ﹤0.01% 3768
2022
Q2 		$38K Buy
1,235
+535
+76% +$18.3K ﹤0.01% 2151
2022
Q1 		$28K Buy
700
+500
+250% +$22.1K ﹤0.01% 2757
2021
Q4 		$8K Buy
+200
New +$9.05K ﹤0.01% 3849
2021
Q3 		– Sell
-500
Closed -$31K – 5831
2021
Q2 		$31K Buy
500
+100
+25% +$6.42K ﹤0.01% 2896
2021
Q1 		$37K Sell
400
-710
-64% -$72.7K ﹤0.01% 2659
2020
Q4 		$99K Buy
1,110
+710
+178% +$65.2K ﹤0.01% 1532
2020
Q3 		$41K Buy
+400
New +$43.1K ﹤0.01% 1920
2016
Q4 		– Sell
-300
Closed -$8.99K – 6671
2016
Q3 		$9K Sell
300
-2,500
-89% -$72.6K ﹤0.01% 4299
2016
Q2 		$78K Buy
+2,800
New +$110K ﹤0.01% 1918

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's EBS Position: Q4 2022 in Review

Cutler Group sold out of Emergent Biosolutions (EBS) in Q4 2022, closing a stake of 203 shares — an estimated $4K sold.

Cutler Group first reported a position in EBS in Q2 2016 and held it in 10 quarters. The position peaked at $99K in Q4 2020. 198 funds tracked by Wall St. Rank hold EBS as of Q4 2022.

  • Cutler Group reported no remaining Emergent Biosolutions position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 203 Emergent Biosolutions shares in Q4 2022, an estimated $4K.
  • Cutler Group first reported a position in Emergent Biosolutions in Q2 2016 and held it in 10 quarters.
  • Cutler Group's Emergent Biosolutions position peaked at $99K in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.